Status:
COMPLETED
Pulmonary Hypertension in Lymphangioleiomyomatosis
Lead Sponsor:
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
Collaborating Sponsors:
Hospices Civils de Lyon
Conditions:
Lymphangioleiomyomatosis
Pulmonary Hypertension
Eligibility:
FEMALE
18+ years
Brief Summary
This is a descriptive study of patients with Lymphangioleiomyomatosis and precapillary pulmonary hypertension.
Detailed Description
Descriptive study of patients with Lymphangioleiomyomatosis and precapillary pulmonary hypertension This will include modality of diagnosis of lLymphangioleiomyomatosis, results of right-sided heart c...
Eligibility Criteria
Inclusion
- Lymphangioleiomyomatosis (definite or probable), either sporadic or associated with tuberous sclerosis
- Precapillary pulmonary hypertension, as defined by right-sided heart catheterization (mean pulmonary artery pressure higher than 25 mmHg, wedge capillary pulmonary pressure less than 15 mmHg, pulmonary vascular resistance higher than 3 Wood units)
Exclusion
- Post capillary pulmonary hypertension
- Other identifiable causes of pulmonary hypertension (ex: thromboembolic disease)
- Not willing to participate
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00960895
Start Date
August 1 2009
End Date
December 1 2010
Last Update
October 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Louis Pradel Hospital
Lyon, University of Lyon, France, 69677